Instil Bio Statistics
Share Statistics
Instil Bio has 6.53M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 6.53M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 3.05M |
| Failed to Deliver (FTD) Shares | 925 |
| FTD / Avg. Volume | 0.47% |
Short Selling Information
The latest short interest is 376.00K, so 5.76% of the outstanding shares have been sold short.
| Short Interest | 376.00K |
| Short % of Shares Out | 5.76% |
| Short % of Float | 12.37% |
| Short Ratio (days to cover) | 2.29 |
Valuation Ratios
The PE ratio is -0.32 and the forward PE ratio is -3.
| PE Ratio | -0.32 |
| Forward PE | -3 |
| PS Ratio | 0 |
| Forward PS | 5.4 |
| PB Ratio | 0.22 |
| P/FCF Ratio | -0.48 |
| PEG Ratio | n/a |
Enterprise Valuation
Instil Bio Inc. has an Enterprise Value (EV) of -.
| EV / Earnings | null |
| EV / Sales | null |
| EV / EBITDA | null |
| EV / EBIT | null |
| EV / FCF | null |
Financial Position
The company has a current ratio of 15.22, with a Debt / Equity ratio of 0.36.
| Current Ratio | 15.22 |
| Quick Ratio | 15.22 |
| Debt / Equity | 0.36 |
| Total Debt / Capitalization | 26.5 |
| Cash Flow / Debt | -1.01 |
| Interest Coverage | -30.56 |
Financial Efficiency
Return on equity (ROE) is -0.69% and return on capital (ROIC) is -51.03%.
| Return on Equity (ROE) | -0.69% |
| Return on Assets (ROA) | -0.48% |
| Return on Capital (ROIC) | -51.03% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -3.19M |
| Employee Count | 49 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 217.51% in the last 52 weeks. The beta is 1.74, so Instil Bio 's price volatility has been higher than the market average.
| Beta | 1.74 |
| 52-Week Price Change | 217.51% |
| 50-Day Moving Average | 31.05 |
| 200-Day Moving Average | 20.74 |
| Relative Strength Index (RSI) | 37.93 |
| Average Volume (20 Days) | 198.80K |
Income Statement
In the last 12 months, Instil Bio had revenue of $0 and earned -$156.09M in profits. Earnings per share was $-24.
| Revenue | 0 |
| Gross Profit | -4.76M |
| Operating Income | -159.17M |
| Net Income | -156.09M |
| EBITDA | -146.12M |
| EBIT | - |
| Earnings Per Share (EPS) | -24 |
Balance Sheet
The company has $9.20M in cash and $86.05M in debt, giving a net cash position of -$76.86M.
| Cash & Cash Equivalents | 9.20M |
| Total Debt | 86.05M |
| Net Cash | -76.86M |
| Retained Earnings | -580.98M |
| Total Assets | 272.56M |
| Working Capital | 122.29M |
Cash Flow
In the last 12 months, operating cash flow was -$82.03M and capital expenditures -$20.66M, giving a free cash flow of -$102.69M.
| Operating Cash Flow | -82.03M |
| Capital Expenditures | -20.66M |
| Free Cash Flow | -102.69M |
| FCF Per Share | -15.79 |
Margins
Gross margin is 0%, with operating and profit margins of 0% and 0%.
| Gross Margin | 0% |
| Operating Margin | 0% |
| Pretax Margin | 0% |
| Profit Margin | 0% |
| EBITDA Margin | n/a% |
| EBIT Margin | n/a% |
| FCF Margin | n/a% |
Dividends & Yields
TIL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -109.39% |
| FCF Yield | -71.72% |
Analyst Forecast
The average price target for TIL is $110, which is 401.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $110 |
| Price Target Difference | 401.4% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
Stock Splits
The last stock split was on Dec 8, 2023. It was a backward split with a ratio of 1:20.
| Last Split Date | Dec 8, 2023 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | -2.68 |
| Piotroski F-Score | 2 |